Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

56.64
Delayed Data
As of Jan 12
 +0.46 / +0.82%
Today’s Change
41.64
Today|||52-Week Range
60.29
+5.06%
Year-to-Date

Today’s Trading

Previous close56.18
Today’s open56.27
Day’s range55.79 - 56.96
Volume53,185
Average volume (3 months)68,390
Market cap$830.5M
Data as of 4:00pm ET, 01/12/2018

Growth & Valuation

Earnings growth (last year)+6.97%
Earnings growth (this year)-10.47%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+11.16%
P/E ratio26.7
Price/Sales7.16
Price/Book3.72

Competitors

 Today’s
change
Today’s
% change
ATRCAtriCure Inc+0.04+0.23%
LMNXLuminex Corp+0.22+1.07%
CRYCryoLife Inc-0.20-1.06%
LMATLeMaitre Vascular In...+0.68+2.13%
Data as of 4:15pm ET, 01/12/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)$0.46
Annual revenue (last year)$103.4M
Annual profit (last year)$32.5M
Net profit margin31.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Charles H. Sherwood
President
Joseph G. Darling
Corporate headquarters
Bedford, Massachusetts

Forecasts